
806 Phase 2 study of first line chemotherapy using CT-2103 (XYOTAX) in patients with non-small-cell lung cancer who are > 69 years of age or who have performance status (PS) = 2
D. Bodkin, M. Neubauer, M.G. BoltonVolume:
1
Année:
2003
Langue:
english
DOI:
10.1016/s1359-6349(03)90831-7
Fichier:
PDF, 170 KB
english, 2003